Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Asset Utilization Ratio (2016 - 2025)

United Therapeutics' Asset Utilization Ratio history spans 16 years, with the latest figure at 0.42 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 41.88% year-over-year to 0.42; the TTM value through Dec 2025 reached 0.42, up 41.88%, while the annual FY2025 figure was 0.42, 5.44% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.42 at United Therapeutics, up from 0.31 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.42 in Q4 2025 and bottomed at 0.24 in Q4 2023.
  • The 5-year median for Asset Utilization Ratio is 0.32 (2023), against an average of 0.32.
  • The largest annual shift saw Asset Utilization Ratio fell 26.24% in 2023 before it surged 41.88% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2021, then dropped by 0.74% to 0.33 in 2022, then dropped by 26.24% to 0.24 in 2023, then increased by 21.95% to 0.29 in 2024, then skyrocketed by 41.88% to 0.42 in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Asset Utilization Ratio are 0.42 (Q4 2025), 0.31 (Q3 2025), and 0.3 (Q2 2025).